16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
E6E99
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
3J71

Guangdong Blue Treasure Pharmaceuticals Co., Ltd.

About Guangdong Blue Treasure Pharmaceuticals Co., Ltd.

Blue Treasure is dedicated to the research and development, manufacture and distribution of APIs and Intermediates by classical fermentation processes. Our current product profile includes Pravastatin Sodium (API) , Tacrolimus APIs and Mycophenolic Acid (intermediate/starting material). 
Our factory has been inspected and approved by China MPA, US FDA, TGA and Korean MFDS, and PMDA. In addition, COS/CEP, Written Confirmation, and COPP are obtained. The company's products are exported around the globe.

Certifications

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Distributor/Import Export
Manufacturer/Innovator
Primary activities
API Producer
Contact info

Products from Guangdong Blue Treasure Pharmaceuticals Co., Ltd. (3)

  • Pravastatin Sodium

    Product Pravastatin Sodium

    • Specification: USP, EP, JP, ChP • China NMPA, US FDA, Korean MFDS, PMDA approved • CEP  • WC • COPP
  • Mycophenolic Acid

    Product Mycophenolic Acid

    • High-quality • Prompt Shipment
  • Tacrolimus

    Product Tacrolimus

    Tacrolimus API to be launched